𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Growth inhibition by anti-estrogens and progestins in TGF-β-resistant and -sensitive breast-tumor cells

✍ Scribed by Eric Kalkhoven; Eliana Beraldi; M. Luisa Panno; Johan P. De Winter; Jos H. H. Thijssen; Bart Van der Burg

Publisher
John Wiley and Sons
Year
1996
Tongue
French
Weight
738 KB
Volume
65
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Transforming growth factor p (TGF-p) is a potent growth inhibitor of non-malignant breast tissue, and TGF-p resistance could play a role in tumorigenesis. Treatment of breast-tumor cells with anti-estrogens and progestins has been shown to correlate with an increase in the levels of secreted TGF-p, suggesting that the growth inhibition observed with these (anti)hormones is mediated by this growth factor. In the present study we have investigated the effects of anti-estrogens and progestins on breast-tumor cell lines, which are either resistant or sensitive to TGF-p. A hormone-independent variant of the MCF7 cell line is shown to have lost its sensitivity to TGF-p during its progression towards an autonomous phenotype, but has preserved its sensitivity to anti-estrogens. In addition, evidence is presented showing that progestins and anti-estrogens inhibit proliferation, irrespective of the sensitivity to TGF-P in variants of the T47D cell line. Therefore, we conclude that, although TGF-p seems an important growth inhibitor for mammary epithelial cells, both progestins and anti-estrogens can inhibit cell proliferation independent of induced TGF-p production.

📜 SIMILAR VOLUMES

The role of TGF-β production in growth i
The role of TGF-β production in growth inhibition of breast-tumor cells by progestins
✍ Eric Kalkhoven; Linda Kwakkenbos-Isbrücker; Christine L. Mummery; Siegfried W. D 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 French ⚖ 801 KB

We have studied the influence of synthetic progestins on the estrogen-induced proliferation and type-p transforming-growthfactor (TGF-p) production of 3 breast-tumor cell lines. In long-term growth experiments, progestins inhibited proliferation of T47D cells, while a specific T47D variant and MCF7

Autocrine TGFβ signaling mediates vitami
Autocrine TGFβ signaling mediates vitamin D3 analog-induced growth inhibition in breast cells
✍ Limin Yang; Junhua Yang; Srinivas Venkateswarlu; Tien Ko; Michael G. Brattain 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 280 KB

In this study, we address whether TGFbeta signaling mediates vitamin D3 analog-induced growth inhibition in nonmalignant and malignant breast cells. Normal mammary epithelial cells (184), immortalized nonmalignant mammary epithelial cells (184A1 and MCF10A), and breast cancer cells (early passage MC

Estrogen receptor-negative breast cancer
Estrogen receptor-negative breast cancer cells transfected with the estrogen receptor exhibit increased RARα gene expression and sensitivity to growth inhibition by retinoic acid
✍ M. Saeed Sheikh; Zhi-Ming Shao; Jian-Chyi Chen; Arif Hussain; Anton M. Jetten; J 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 968 KB

We and others have shown previously that retinoic acid (RA) selectively inhibits the growth of estrogen receptor (ER)-positive human breast carcinoma (HBC) cells and ER-negative cells are refractory to RA inhibition o f growth. The ER-negative cells inherently express lower levels of RARa and retino

Transforming growth factor β1 (TGF-β1) i
Transforming growth factor β1 (TGF-β1) inhibits growth of a human ovarian carcinoma cell line (OVCCR1) and is expressed in human ovarian tumors
✍ S. Jozan; M. Guerrin; P. Mazars; M. Dutaur; B. Monsarrat; F. Cheutin; R. Bugat; 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 French ⚖ 957 KB

## Abstract The effects of EGF and TGF‐β1 on the proliferation of 2 ovarian carcinoma cell lines (IGROV1 and OVCCR1) were evaluated. The cell lines were adapted to grow in a restricted serum (0.5%) medium. EGF was required for proliferation of both ovarian cell lines. Low doses of TGF‐β1 inhibited

Antitumor effects of interferon in mice
Antitumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant friend leukemia cells. III. Inhibition of growth and necrosis of tumors implanted subcutaneously
✍ F. Belardelli; I. Gresser; C. Maury; P. Duvillard; M. Prade; M.-T. Maunoury 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 French ⚖ 636 KB

## Abstract Administration of highly purified interferon to DA/2 mice inhibited the growth of interferon‐sensitive or interferon‐resistant Friend erythroleukemia cells implanted subcutaneously. Injection of interferon at the site of tumor inoculation was more effective than injection of interferon

Anti-tumor effects of interferon in mice
Anti-tumor effects of interferon in mice injected with interferon-sensitive and interferon-resistant friend erythroleukemia cells. VIII. Role of the immune system in the inhibition of visceral metastases
✍ Ion Gresser; Chantal Maury; Claude Carnaud; Edward De Maever; Marie-Thérése Maun 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 758 KB

DBAl2 mice were injected i.v. with IFN alp-resistant 3C I 8 Friend erythroleukemia cells (FLC) which metastasize to the liver and spleen. IFN d p treatment of FLC-injected mice increased their survival time and these mice developed a resistance to a second challenge with FLC. The efficacy of IFN d p